Literature DB >> 29065947

TAKING PATIENT HETEROGENEITY AND PREFERENCES INTO ACCOUNT IN HEALTH TECHNOLOGY ASSESSMENTS.

Wietske Kievit1, Marcia Tummers2, Ralph van Hoorn2, Andrew Booth3, Kati Mozygemba4, Pietro Refolo5, Dario Sacchini5, Lisa Pfadenhauer6, Ansgar Gerhardus4, Gert Jan Van der Wilt7.   

Abstract

OBJECTIVES: The INTEGRATE-HTA project provided methodology to evaluate complex technologies. This study provides guidance on how to retrieve and critically appraise available evidence on moderators and predictors of treatment effects and on patient preferences for treatment outcomes as a source of complexity.
METHODS: Search filters for PubMed were developed by hand-searching a large volume of articles reporting on relevant aspects. Search terms were retrieved from selected papers and algorithmically combined to find the optimal combination of search terms. For the development of the appraisal checklists literature was searched in PubMed and Google Scholar together with citation chasing. For the CHecklist for the Appraisal of Moderators and Predictors (CHAMP) a Delphi procedure was used to value a set of eligible appraisal criteria retrieved from the literature.
RESULTS: Search filters were developed optimized for different accuracy measures. The final version of CHAMP consists of a seventeen questions covering the design, analysis, results and transferability of results of moderator and predictor analysis. The final checklist for appraisal of literature on patient preferences for treatment outcomes consist of six questions meant to help the user to identify relevant quality issues together with a guidance toward existing tools concerning the appraisal of specific preference elicitation methods.
CONCLUSIONS: Incorporating knowledge on subgroups for whom a specific treatment will produce more benefit holds the promise of better targeting and, ultimately, enhancing overall effectiveness and efficiency of healthcare technology. Finally, incorporating information on preferences for treatment outcomes will foster health technology assessment that addresses outcomes that are important to patients.

Entities:  

Keywords:  Complex interventions; Health technology assessment; INTEGRATE-HTA; Moderators; Patient preferences; Predictors

Mesh:

Year:  2017        PMID: 29065947     DOI: 10.1017/S0266462317000885

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  10 in total

1.  Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs.

Authors:  Nigel S Cook; Julie Cave; Anke-Peggy Holtorf
Journal:  Front Med (Lausanne)       Date:  2019-04-24

2.  Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US.

Authors:  Chiara Whichello; Eline van Overbeeke; Rosanne Janssens; Karin Schölin Bywall; Selena Russo; Jorien Veldwijk; Irina Cleemput; Juhaeri Juhaeri; Bennett Levitan; Jürgen Kübler; Meredith Smith; Richard Hermann; Matthias Englbrecht; Axel J Hueber; Alina Comanescu; Sarah Harding; Steven Simoens; Isabelle Huys; Esther W de Bekker-Grob
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

3.  Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study.

Authors:  Eline van Overbeeke; Rosanne Janssens; Chiara Whichello; Karin Schölin Bywall; Jenny Sharpe; Nikoletta Nikolenko; Berkeley S Phillips; Paolo Guiddi; Gabriella Pravettoni; Laura Vergani; Giulia Marton; Irina Cleemput; Steven Simoens; Jürgen Kübler; Juhaeri Juhaeri; Bennett Levitan; Esther W de Bekker-Grob; Jorien Veldwijk; Isabelle Huys
Journal:  Front Pharmacol       Date:  2019-12-03       Impact factor: 5.810

4.  Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients.

Authors:  Ilaria Durosini; Rosanne Janssens; Reinhard Arnou; Jorien Veldwijk; Meredith Y Smith; Dario Monzani; Ian Smith; Giulia Galli; Marina Garassino; Eva G Katz; Luca Bailo; Evelyne Louis; Marie Vandevelde; Kristiaan Nackaerts; G Ardine de Wit; Gabriella Pravettoni; Isabelle Huys
Journal:  Front Public Health       Date:  2021-02-05

5.  Family involvement in advance care planning for people living with advanced cancer: A systematic mixed-methods review.

Authors:  Megumi Kishino; Clare Ellis-Smith; Oladayo Afolabi; Jonathan Koffman
Journal:  Palliat Med       Date:  2022-01-06       Impact factor: 4.762

6.  Development of a Quantitative Preference Instrument for Person-Centered Dementia Care-Stage 2: Insights from a Formative Qualitative Study to Design and Pretest a Dementia-Friendly Analytic Hierarchy Process Survey.

Authors:  Wiebke Mohr; Anika Rädke; Adel Afi; Franka Mühlichen; Moritz Platen; Annelie Scharf; Bernhard Michalowsky; Wolfgang Hoffmann
Journal:  Int J Environ Res Public Health       Date:  2022-07-13       Impact factor: 4.614

7.  Examining patient and professional perspectives in the UK for gene therapy in haemophilia.

Authors:  Ione Woollacott; George Morgan; Pratima Chowdary; Jamie O'Hara; Bethany Franks; Eline van Overbeeke; Nicola Dunn; Sissel Michelsen; Isabelle Huys; Antony Martin; Matthew Cawson; Jack Brownrigg; Ian Winburn; Jim Thomson
Journal:  Haemophilia       Date:  2022-04-19       Impact factor: 4.263

8.  Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

Authors:  Rosanne Janssens; Isabelle Huys; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Antonio Ciaglia; Steven Simoens; Hilde Stevens; Meredith Smith; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-04       Impact factor: 2.796

9.  Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives.

Authors:  Eline van Overbeeke; Valérie Forrester; Steven Simoens; Isabelle Huys
Journal:  Patient       Date:  2021-01       Impact factor: 3.883

10.  Use of Patient Preference Information in Benefit-Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives.

Authors:  Lylia Chachoua; Monique Dabbous; Clément François; Claude Dussart; Samuel Aballéa; Mondher Toumi
Journal:  Front Med (Lausanne)       Date:  2020-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.